A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the superiority of KCT-0809 to placebo, and to evaluate safety in dry eye patients with Sjögren's syndrome

• Phase: Phase 3

Details

• Lead Sponsor: Kissei Pharmaceutical Co., Ltd.
• Treatments: Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Dry eye patients with Sjögren's syndrome

• Corneal and conjunctival damage

Exclusion Criteria:

• Severe ophthalmic disorder

• Punctal plugs or surgery for occlusion of the lacrimal puncta